drugset / Trial / NCT00195234
Study Evaluating Vaccine in Adults With HIV
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to learn whether the study vaccine and adjuvants (drugs that are used to help improve immune responses) have an acceptable safety profile in treating individuals with HIV. A second purpose of this study is to understand how the immune system responds to the study vaccine and adjuvants.
Timeline
- Start
- 2004-12
- Primary completion
- —
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HIV CTL MEP | Vaccine | 1000 ug | — |